Overall, these findings reveal that loss of Bscl2 specifically in developing adipocytes is sufficient to cause generalised lipodystrophy in early life in vivo, leading to several, but not all, clinical features observed in CGL2 patients and global Bscl2 knockout mice. Here, GZMH is linked to lipodystrophy.